Related Experiment Videos
The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin
J Carmichael1, B M Cantwell, C M Edwards
1University Department of Clinical Oncology, Newcastle General Hospital, Newcastle upon Tyne.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Cancer research·2001
The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research·2000
[Sacituzumab govitecan in a patient with early bone recurrence of triple-negative breast cancer refractory to first-line chemotherapy.]
Recenti progressi in medicina·2026
Quercetin Attenuates Cisplatin-Induced Nephrotoxicity While Enhancing Antitumor Efficacy in Gastric Cancer via Cell Type-Specific Modulation of the ERK1/2 Pathway.
Journal of biochemical and molecular toxicology·2026
Gedatolisib for the treatment of hormone receptor-positive/HER2-negative advanced breast cancer: a European perspective.
Future oncology (London, England)·2026
Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation for the Treatment of Early-Stage Hepatocellular Carcinoma.
Journal of medical imaging and radiation oncology·2026